483 TEVA Pharmaceuticals USA Feb 2017

483 TEVA Pharmaceuticals USA Feb 2017

Niketa Patel FDA, Helen Verdel FDA$119.00 - Available Now

FDA investigators audited the TEVA Pharmaceuticals USA - Fairfield, NJ, United States facility and issued 1 inspectional observation (via FDA 483) on 01 Feb 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 1
  • Inspection end: 01 Feb 2017
  • Location: Fairfield, United States
  • FEI: 2245641
Add To Cart